What is the definition of acute kidney injury (AKI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Definition of Acute Kidney Injury (AKI)

AKI is defined by the KDIGO criteria as any one of the following: (1) serum creatinine rise ≥0.3 mg/dL (≥26 μmol/L) within 48 hours, OR (2) serum creatinine rise ≥50% from baseline within 7 days, OR (3) urine output <0.5 mL/kg/hour for more than 6 hours 1.

Diagnostic Criteria

AKI diagnosis requires meeting any one of these functional criteria:

Serum Creatinine Criteria:

  • Absolute rise: ≥0.3 mg/dL (≥26 μmol/L) within 48 hours
  • Relative rise: ≥50% (1.5-fold) increase from baseline within 7 days

Urine Output Criteria:

  • <0.5 mL/kg/hour for >6 consecutive hours

The diagnosis is made when a patient meets ANY of these criteria—you do not need both creatinine and urine output changes 1.

Staging System

Once AKI is detected, severity is staged retrospectively based on the maximum degree of dysfunction:

Stage 1:

  • Creatinine: 1.5-1.9× baseline OR ≥0.3 mg/dL rise
  • Urine output: <0.5 mL/kg/hour for >6 hours

Stage 2:

  • Creatinine: 2.0-2.9× baseline
  • Urine output: <0.5 mL/kg/hour for >12 hours

Stage 3:

  • Creatinine: ≥3.0× baseline OR ≥4.0 mg/dL (≥354 μmol/L) with acute rise OR initiation of renal replacement therapy
  • Urine output: <0.3 mL/kg/hour for ≥24 hours OR anuria for ≥12 hours

1

Critical Nuances

The Baseline Problem

The creatinine baseline should ideally be the lowest value within the prior 7 days. When unavailable, baseline may be presumed based on patient history, though this introduces diagnostic uncertainty 1.

AKI vs. Acute Kidney Disease (AKD)

AKI is a subset of AKD—the broader term encompassing any kidney dysfunction lasting <3 months. AKI specifically requires the functional changes to occur within the defined timeframes (48 hours or 7 days). AKD includes slower deteriorations that don't meet AKI velocity criteria but still represent acute processes 2, 1.

Common Pitfalls

Oliguria alone triggers diagnosis: Many clinicians wait for creatinine changes, but urine output <0.5 mL/kg/hour for >6 hours alone defines Stage 1 AKI and should prompt immediate evaluation—do not wait for creatinine to rise 1.

The Stage 3 CKD trap: A patient with CKD whose creatinine rises to ≥4.0 mg/dL (even with only a 0.3 mg/dL or 50% rise) is automatically classified as Stage 3 AKI, whereas the same absolute rise in someone without CKD would only be Stage 1. This creates prognostic heterogeneity within staging 1.

Creatinine lags injury: Serum creatinine rises 24-48 hours after the actual kidney injury occurs. The KDIGO definition captures functional decline, not the injury itself. Emerging biomarkers (TIMP-2, IGFBP7, NGAL) can detect structural damage earlier, though they are not yet part of the standard definition 3.

Prognostic Significance

Even small creatinine rises (≥0.3 mg/dL) independently predict approximately 4-fold increased hospital mortality, establishing why this threshold was incorporated into the definition 1. AKI of any stage increases long-term risks of chronic kidney disease, cardiovascular events, and death 2, 4, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.